Serveur d'exploration sur la rapamycine et les champignons - Corpus (Accueil)

Index « MedMesh.i » - entrée « Disease Progression »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Disease Outbreaks < Disease Progression < Disease Reservoirs  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]
Ident.Authors (with country if any)Title
000075 (2020) Loukman Omarjee ; Anne Janin ; Frédérique Perrot ; Bruno Laviolle ; Olivier Meilhac ; Guillaume MaheTargeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19.
000080 (2020) Ling Xu ; Cuili Zhang ; Dan He ; Nan Jiang ; Ying Bai ; Yi XinRapamycin and MCC950 modified gut microbiota in experimental autoimmune encephalomyelitis mouse by brain gut axis.
000138 (2019) Samantha S. Eckley ; Johanna M. Buschhaus ; Brock A. Humphries ; Tanner H. Robison ; Kathryn E. Luker ; Gary D. LukerShort-Term Environmental Conditioning Enhances Tumorigenic Potential of Triple-Negative Breast Cancer Cells.
000324 (2019) Karen E. Ocwieja ; Sara O. Vargas ; Scott A. Elisofon ; David S. Shulman ; Christine K. Lee ; Rima Fawaz ; Natalie Collins ; Khashayar Vakili ; Tanvi S. SharmaPediatric post-transplant hepatic kaposi sarcoma due to donor-derived human herpesvirus 8.
000330 (2019) Congcong Gong ; Yang Hu ; Mao Zhou ; Maojin Yao ; Zhengxiang Ning ; Zhi Wang ; Jiaoyan RenIdentification of specific modules and hub genes associated with the progression of gastric cancer.
000412 (2018) Ze Rui Wu ; Lichong Yan ; Yan Ting Liu ; Lei Cao ; Yu Hang Guo ; Yong Zhang ; Hong Yao ; Lin Cai ; Han Bing Shang ; Wei Wei Rui ; Gang Yang ; Xiao Biao Zhang ; Hao Tang ; Yu Wang ; Jin Yan Huang ; Yong Xu Wei ; Wei Guo Zhao ; Bing Su ; Zhe Bao WuInhibition of mTORC1 by lncRNA H19 via disrupting 4E-BP1/Raptor interaction in pituitary tumours.
000513 (2018) Angela Kwok-Fung Lo ; Raymond Wai-Ming Lung ; Christopher W. Dawson ; Lawrence S. Young ; Chuen-Wai Ko ; Walter Wai Yeung ; Wei Kang ; Ka-Fai To ; Kwok-Wai LoActivation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
000554 (2018) Olga Katsara ; Victoria KolupaevamTOR-mediated inactivation of 4E-BP1, an inhibitor of translation, precedes cartilage degeneration in rat osteoarthritic knees.
000719 (2017) Dominik Horn ; Christian Freudlsperger ; Dana Holzinger ; Kevin Kunzmann ; Peter Plinkert ; Gerhard Dyckhoff ; Jürgen Hoffmann ; Kolja Freier ; Jochen HessUpregulation of pAKT(Ser473) expression in progression of HPV-positive oropharyngeal squamous cell carcinoma.
000749 (2017) Inan Olmez ; Breanna Brenneman ; Aizhen Xiao ; Vlad Serbulea ; Mouadh Benamar ; Ying Zhang ; Laryssa Manigat ; Tarek Abbas ; Jeongwu Lee ; Ichiro Nakano ; Jakub Godlewski ; Agnieszka Bronisz ; Roger Abounader ; Norbert Leitinger ; Benjamin PurowCombined CDK4/6 and mTOR Inhibition Is Synergistic against Glioblastoma via Multiple Mechanisms.
000790 (2017) Ching-Tai Huang ; Chen-Yiu Hung ; Tse-Ching Chen ; Chun-Yen Lin ; Yung-Chang Lin ; Chia-Shiang Chang ; Yueh-Chia He ; Yu-Lin Huang ; Avijit DuttaRapamycin adjuvant and exacerbation of severe influenza in an experimental mouse model.
000888 (2017) Chengfeng Bi ; Xuan Zhang ; Ting Lu ; Xiaoyan Zhang ; Xianhuo Wang ; Bin Meng ; Huilai Zhang ; Ping Wang ; Julie M. Vose ; Wing C. Chan ; Timothy W. Mckeithan ; Kai FuInhibition of 4EBP phosphorylation mediates the cytotoxic effect of mechanistic target of rapamycin kinase inhibitors in aggressive B-cell lymphomas.
000953 (2016) David R. Driscoll ; Saadia A. Karim ; Makoto Sano ; David M. Gay ; Wright Jacob ; Jun Yu ; Yusuke Mizukami ; Aarthi Gopinathan ; Duncan I. Jodrell ; T R Jeffry Evans ; Nabeel Bardeesy ; Michael N. Hall ; Brian J. Quattrochi ; David S. Klimstra ; Simon T. Barry ; Owen J. Sansom ; Brian C. Lewis ; Jennifer P. MortonmTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer.
000C58 (2015) S. Mourah ; R. Porcher ; M. Battistella ; D. Kerob ; B. Guillot ; T. Jouary ; F. Agbalika ; F. Morinet ; V. Furlan ; H M Teisserenc ; N. Dupin ; C. LebbéParadoxical simultaneous regression and progression of lesions in a phase II study of everolimus in classic Kaposi sarcoma.
000D51 (2014) Ariadne Vlahakis ; Ted PowersA role for TOR complex 2 signaling in promoting autophagy.
000D76 (2015) Rui Zhang ; Yanhua Cao ; Lan Bai ; Chengliang Zhu ; Rui Li ; Hui He ; Yingle Liu ; Kailang Wu ; Fang Liu ; Jianguo WuThe collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades.
000D89 (2015) Faouzi Saliba ; Frederik NevensProgression of liver fibrosis in HCV-positive liver transplant recipients randomized to everolimus with reduced calcineurin inhibitor (CNI) therapy or a standard CNI regimen.
000F16 (2014) Shilpak Chatterjee ; Jonathan M. Eby ; Amir A. Al-Khami ; Myroslawa Soloshchenko ; Hee-Kap Kang ; Navtej Kaur ; Osama S. Naga ; Anuradha Murali ; Michael I. Nishimura ; I. Caroline Le Poole ; Shikhar MehrotraA quantitative increase in regulatory T cells controls development of vitiligo.
000F67 (2013) Eleonora Teplinsky ; Derrick Cheung ; Ilan Weisberg ; Ramon E A. Jacobs ; Martin Wolff ; James Park ; Kent Friedman ; Franco Muggia ; Komal JhaveriFatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature.
001104 (2013) Partab Rai ; Andrei Plagov ; Dileep Kumar ; Shresh Pathak ; Kamesh R. Ayasolla ; Amrita K. Chawla ; Peter W. Mathieson ; Moin A. Saleem ; Mohammad Husain ; Ashwani Malhotra ; Pravin C. SinghalRapamycin-induced modulation of HIV gene transcription attenuates progression of HIVAN.
001243 (2011) G J Mckenna ; J F Trotter ; E. Klintmalm ; N. Onaca ; R. Ruiz ; L W Jennings ; M. Neri ; J G O'Leary ; G L Davis ; M F Levy ; R M Goldstein ; G B KlintmalmLimiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppression.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i -k "Disease Progression" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i  \
                -Sk "Disease Progression" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Disease Progression
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020